4552 — JCR Pharmaceuticals Co Balance Sheet
0.000.00%
- ¥59bn
- ¥76bn
- ¥43bn
- 34
- 37
- 17
- 16
Annual balance sheet for JCR Pharmaceuticals Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 11,193 | 26,260 | 30,977 | 13,278 | 18,756 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 7,977 | 8,183 | 15,585 | 11,137 | 14,934 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 28,342 | 48,545 | 62,188 | 47,802 | 57,581 |
Net Property, Plant And Equipment | 14,875 | 17,172 | 26,782 | 32,681 | 30,040 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 47,775 | 73,784 | 97,134 | 94,937 | 102,226 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 10,434 | 29,028 | 42,054 | 35,762 | 30,135 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 15,385 | 35,401 | 46,250 | 42,775 | 46,048 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 32,390 | 38,383 | 50,884 | 52,162 | 56,178 |
Total Liabilities & Shareholders' Equity | 47,775 | 73,784 | 97,134 | 94,937 | 102,226 |
Total Common Shares Outstanding |